Works matching IS 00912700 AND DT 2015 AND VI 55 AND IP 9

Results: 14

Effect of ceralifimod (ONO-4641) on lymphocytes and cardiac function: Randomized, double-blind, placebo-controlled trial with an open-label fingolimod arm.

Published in:

Journal of Clinical Pharmacology, 2015, v. 55, n. 9, p. 1051, doi. 10.1002/jcph.513

By:

Krösser, Sonja;
Wolna, Peter;
Fischer, Tanya Z.;
Boschert, Ursula;
Stoltz, Randall;
Zhou, Meijian;
Darpo, Borje

Publication type:

Article

Pharmacokinetic (PK) drug interaction studies of cabozantinib: Effect of CYP3A inducer rifampin and inhibitor ketoconazole on cabozantinib plasma PK and effect of cabozantinib on CYP2C8 probe substrate rosiglitazone plasma PK.

Published in:

Journal of Clinical Pharmacology, 2015, v. 55, n. 9, p. 1012, doi. 10.1002/jcph.510

By:

Nguyen, Linh;
Holland, Jaymes;
Miles, Dale;
Engel, Caroline;
Benrimoh, Natacha;
O'Reilly, Terry;
Lacy, Steven

Publication type:

Article

Pharmacokinetics of hepatitis C virus NS5A inhibitor JNJ-56914845 (GSK2336805) in subjects with hepatic impairment.

Published in:

Journal of Clinical Pharmacology, 2015, v. 55, n. 9, p. 1042, doi. 10.1002/jcph.512

By:

Adkison, Kimberly K.;
Gan, Jianjun;
Elko‐Simms, Lucinda;
Gardner, Stephen;
Dumont, Etienne;
Jones, Lori S.;
Saunders, Joanne;
Marbury, Thomas;
Smith, William;
Berg, Jolene;
Galloway, Christopher;
Stump, Patrick J.

Publication type:

Article

Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet®), sustained-release carbidopa-levodopa (Sinemet® CR), and carbidopa-levodopa-entacapone (Stalevo®)

Published in:

Journal of Clinical Pharmacology, 2015, v. 55, n. 9, p. 995, doi. 10.1002/jcph.514

By:

Hsu, Ann;
Yao, Hsuan‐Ming;
Gupta, Suneel;
Modi, Nishit B.

Publication type:

Article

Effect of multiple intravenous doses of lanicemine (AZD6765) on the pharmacokinetics of midazolam in healthy subjects.

Published in:

Journal of Clinical Pharmacology, 2015, v. 55, n. 9, p. 1024, doi. 10.1002/jcph.515

By:

Bui, Khanh H.;
Zhou, Diansong;
Agbo, Felix;
Guo, Jian

Publication type:

Article

A dangerous lack of pharmacology education in medical and nursing schools: A policy statement from the American College of Clinical Pharmacology.

Published in:

Journal of Clinical Pharmacology, 2015, v. 55, n. 9, p. 953, doi. 10.1002/jcph.539

By:

Wiernik, Peter H.

Publication type:

Article

Single-dose evaluation of safety, tolerability and pharmacokinetics of newly formulated hydromorphone immediate-release and hydrophilic matrix extended-release tablets in healthy Japanese subjects without co-administration of an opioid antagonist.

Published in:

Journal of Clinical Pharmacology, 2015, v. 55, n. 9, p. 975, doi. 10.1002/jcph.501

By:

Toyama, Kaoru;
Uchida, Naoki;
Ishizuka, Hitoshi;
Sambe, Takehiko;
Kobayashi, Shinichi

Publication type:

Article

Multiple dose pharmacokinetics of inhaled loxapine in subjects on chronic, stable antipsychotic regimens.

Published in:

Journal of Clinical Pharmacology, 2015, v. 55, n. 9, p. 985, doi. 10.1002/jcph.502

By:

Spyker, Daniel A.;
Riesenberg, Robert A.;
Cassella, James V.

Publication type:

Article

In vitro metabolism of canagliflozin in human liver, kidney, intestine microsomes, and recombinant uridine diphosphate glucuronosyltransferases (UGT) and the effect of genetic variability of UGT enzymes on the pharmacokinetics of canagliflozin in humans.

Published in:

Journal of Clinical Pharmacology, 2015, v. 55, n. 9, p. 1061, doi. 10.1002/jcph.506

By:

Francke, Stephan;
Mamidi, Rao N. V. S.;
Solanki, Bhavna;
Scheers, Ellen;
Jadwin, Andrew;
Favis, Reyna;
Devineni, Damayanthi

Publication type:

Article

Clinical assessment of drug-drug interactions of tasimelteon, a novel dual melatonin receptor agonist.

Published in:

Journal of Clinical Pharmacology, 2015, v. 55, n. 9, p. 1004, doi. 10.1002/jcph.507

By:

Ogilvie, Brian W.;
Torres, Rosarelis;
Dressman, Marlene A.;
Kramer, William G.;
Baroldi, Paolo

Publication type:

Article

Pharmacokinetics, pharmacodynamics, safety, and tolerability of pradigastat, a novel diacylglycerol acyltransferase 1 inhibitor in overweight or obese, but otherwise healthy human subjects.

Published in:

Journal of Clinical Pharmacology, 2015, v. 55, n. 9, p. 1031, doi. 10.1002/jcph.509

By:

Meyers, Charles D.;
Amer, Ahmed;
Majumdar, Tapan;
Chen, Jin

Publication type:

Article

Issue Information.

Published in:: 2015
Publication type:: Other

Management of lipid disorders in patients living with HIV.

Published in:

Journal of Clinical Pharmacology, 2015, v. 55, n. 9, p. 957, doi. 10.1002/jcph.473

By:

Myerson, Merle;
Malvestutto, Carlos;
Aberg, Judith A.

Publication type:

Article

Exodus of clinical pharmacologists and pharmacometricians from academia-Who is to blame? A policy statement from the American College of Clinical Pharmacology.

Published in:

Journal of Clinical Pharmacology, 2015, v. 55, n. 9, p. 955, doi. 10.1002/jcph.542

By:

Upreti, Vijay V.

Publication type:

Article